Recruiting NA Sinus Floor Augmentation

Compares treatment options for Sinus Floor Augmentation

Official title Evaluation of Lateral Sinus Floor Elevation Using Xenograft Versus L-PRF Block Combined With Xenograft

ClinicalTrials.gov ID: NCT07677007

What this study is testing

What it's testing
Rehabilitation of the posterior maxilla with dental implants is frequently complicated by insufficient residual bone height resulting from alveolar ridge resorption and maxillary sinus pneumatization. Lateral sinus floor elevation has become a predictable and widely accepted procedure for increasing bone volume and enabling implant placement in severely atrophic posterior maxillary sites.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 70. Healthy volunteers may be eligible.

You may be able to join if

  • Adults aged 21 years or older.
  • Partially edentulous posterior maxilla requiring implant-supported rehabilitation.
  • Residual bone height between 2 and 5 mm measured by CBCT.
  • Good oral hygiene and compliance with maintenance visits.
  • ASA I or II patients.

You likely can't join if

  • Uncontrolled systemic diseases.
  • Smoking more than 10 cigarettes/day.
  • Active sinus pathology or chronic sinusitis.
  • Previous sinus augmentation surgery.
  • Pregnancy or lactation.
  • Bisphosphonate therapy.
See the full eligibility criteria
Who can join
  • Adults aged 21 years or older.
  • Partially edentulous posterior maxilla requiring implant-supported rehabilitation.
  • Residual bone height between 2 and 5 mm measured by CBCT.
  • Good oral hygiene and compliance with maintenance visits.
  • ASA I or II patients.
  • Signed informed consent.
What rules you out
  • Uncontrolled systemic diseases.
  • Smoking more than 10 cigarettes/day.
  • Active sinus pathology or chronic sinusitis.
  • Previous sinus augmentation surgery.
  • Pregnancy or lactation.
  • Bisphosphonate therapy.
  • Immunocompromised patients.
  • History of head and neck radiotherapy

The study team makes the final eligibility decision.

Where it's taking place

  • Ajman, Ajman Emirate, United Arab Emirates

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Ajman, Ajman Emirate, United Arab Emirates. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.